LAB
Income statement / Annual
Last year (2023), Standard BioTools Inc.'s total revenue was $106.34 M,
an increase of 8.57% from the previous year.
In 2023, Standard BioTools Inc.'s net income was -$74.66 M.
See Standard BioTools Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$106.34 M
|
$97.95 M
|
$130.58 M
|
$138.14 M
|
$117.24 M
|
$112.96 M
|
$101.94 M
|
$104.45 M
|
$114.71 M
|
$116.46 M
|
| Cost of Revenue |
$55.89 M |
$60.90 M |
$61.21 M |
$54.82 M |
$52.96 M |
$51.32 M |
$49.96 M |
$46.01 M |
$46.63 M |
$42.85 M |
| Gross Profit |
$50.45 M |
$37.05 M |
$69.37 M |
$83.33 M |
$64.28 M |
$61.65 M |
$51.98 M |
$58.44 M |
$68.08 M |
$73.61 M |
| Gross Profit Ratio |
0.47 |
0.38 |
0.53 |
0.6 |
0.55 |
0.55 |
0.51 |
0.56 |
0.59 |
0.63 |
| Research and Development
Expenses |
$25.95 M
|
$38.50 M
|
$37.94 M
|
$36.46 M
|
$31.64 M
|
$30.03 M
|
$30.83 M
|
$38.42 M
|
$39.26 M
|
$43.42 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$87.54 M
|
$114.76 M
|
$98.89 M
|
$97.90 M
|
$84.48 M
|
$79.78 M
|
$79.52 M
|
$93.21 M
|
$82.96 M
|
$71.32 M
|
| Other Expenses |
$6.96 M |
-$12.31 M |
$7.63 M |
$507,000.00 |
$1.43 M |
$637,000.00 |
$385,000.00 |
-$1.17 M |
-$1.16 M |
-$857,000.00 |
| Operating Expenses |
$113.49 M |
$153.26 M |
$136.83 M |
$134.36 M |
$116.12 M |
$109.81 M |
$110.34 M |
$131.63 M |
$122.22 M |
$114.75 M |
| Cost And Expenses |
$169.38 M |
$214.15 M |
$198.04 M |
$189.18 M |
$169.08 M |
$161.13 M |
$160.30 M |
$177.64 M |
$168.85 M |
$157.60 M |
| Interest Income |
$0.00 |
$4.33 M |
$291,000.00 |
$307,000.00 |
$1.33 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$4.57 M |
$4.33 M |
$3.82 M |
$3.57 M |
$4.28 M |
$13.89 M |
$5.82 M |
$5.82 M |
$5.81 M |
$5.34 M |
| Depreciation &
Amortization |
$15.18 M
|
$15.03 M
|
$16.07 M
|
$17.94 M
|
$15.81 M
|
$16.50 M
|
$18.30 M
|
$17.94 M
|
$16.12 M
|
$4.06 M
|
| EBITDA |
-$47.86 M
|
-$113.49 M
|
-$44.26 M
|
-$34.61 M
|
-$34.60 M
|
-$30.96 M
|
-$39.37 M
|
-$56.42 M
|
-$39.18 M
|
-$37.94 M
|
| EBITDA Ratio |
-0.45 |
-1.16 |
-0.34 |
-0.25 |
-0.3 |
-0.27 |
-0.39 |
-0.54 |
-0.34 |
-0.33 |
| Operating Income Ratio
|
-0.59
|
-1.19
|
-0.52
|
-0.37
|
-0.44
|
-0.43
|
-0.57
|
-0.7
|
-0.44
|
-0.45
|
| Total Other
Income/Expenses Net |
-$11.17 M
|
-$76.72 M
|
$3.80 M
|
-$3.07 M
|
-$14.87 M
|
$637,000.00
|
$385,000.00
|
-$1.17 M
|
$5.16 M
|
-$11.22 M
|
| Income Before Tax |
-$74.20 M |
-$192.93 M |
-$63.66 M |
-$54.10 M |
-$66.71 M |
-$61.42 M |
-$63.80 M |
-$80.18 M |
-$54.79 M |
-$57.71 M |
| Income Before Tax Ratio
|
-0.7
|
-1.97
|
-0.49
|
-0.39
|
-0.57
|
-0.54
|
-0.63
|
-0.77
|
-0.48
|
-0.5
|
| Income Tax Expense |
$452,000.00 |
-$2.83 M |
-$4.42 M |
-$1.08 M |
-$1.92 M |
-$2.41 M |
-$3.26 M |
-$4.19 M |
-$1.48 M |
-$4.88 M |
| Net Income |
-$74.66 M |
-$190.10 M |
-$59.24 M |
-$53.02 M |
-$64.79 M |
-$59.01 M |
-$60.54 M |
-$75.99 M |
-$53.32 M |
-$52.83 M |
| Net Income Ratio |
-0.7 |
-1.94 |
-0.45 |
-0.38 |
-0.55 |
-0.52 |
-0.59 |
-0.73 |
-0.46 |
-0.45 |
| EPS |
-0.94 |
-2.43 |
-0.78 |
-0.74 |
-0.97 |
-1.49 |
-1.84 |
-2.62 |
-1.86 |
-1.9 |
| EPS Diluted |
-0.94 |
-2.43 |
-0.78 |
-0.74 |
-0.97 |
-1.49 |
-1.84 |
-2.62 |
-1.86 |
-1.9 |
| Weighted Average Shares
Out |
$79.16 M
|
$78.31 M
|
$75.79 M
|
$72.04 M
|
$66.78 M
|
$39.65 M
|
$32.98 M
|
$29.01 M
|
$28.71 M
|
$27.77 M
|
| Weighted Average Shares
Out Diluted |
$79.16 M
|
$78.31 M
|
$75.79 M
|
$72.04 M
|
$66.78 M
|
$39.65 M
|
$32.98 M
|
$29.01 M
|
$28.71 M
|
$27.77 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
